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Spatio-temporal overview 
of neuroinflammation in an 
experimental mouse stroke model
Lara Buscemi  1,2, Melanie Price1,2, Paola Bezzi  2 & Lorenz Hirt  1,2
After ischemic stroke, in the lesion core as well as in the ischemic penumbra, evolution of tissue damage 
and repair is strongly affected by neuroinflammatory events that involve activation of local specialized 
glial cells, release of inflammatory mediators, recruiting of systemic cells and vascular remodelling. To 
take advantage of this intricate response in the quest to devise new protective therapeutic strategies 
we need a better understanding of the territorial and temporal interplay between stroke-triggered 
inflammatory and cell death-inducing processes in both parenchymal and vascular brain cells. Our goal 
is to describe structural rearrangements and functional modifications occurring in glial and vascular cells 
early after an acute ischemic stroke. Low and high scale mapping of the glial activation on brain sections 
of mice subjected to 30 minutes middle cerebral artery occlusion (MCAO) was correlated with that of 
the neuronal cell death, with markers for microvascular changes and with markers for pro-inflammatory 
(IL-1β) and reparative (TGFβ1) cytokines. Our results illustrate a time-course of the neuroinflammatory 
response starting at early time-points (1 h) and up to one week after MCAO injury in mice, with an 
accurate spatial distribution of the observed phenomena.
Stroke is a major public health issue, ranking as second cause of death worldwide and first cause of handicap in 
adults. It also ranks second, after ischemic heart disease for the estimation of lost years of healthy life1. Major 
improvements have been achieved in the acute phase management of ischemic stroke, firstly by expanding the use 
of thrombolysis with recombinant tissue-plasminogen activator in the extended 4.5 h time-window2. Secondly, a 
remarkable efficacy of endovascular clot removal within 7.3 h from symptom onset was recently demonstrated3. 
Carefully selected patients were shown to benefit from endovascular treatment up to 24 h after symptom onset4,5. 
Despite this striking progress, many patients die or remain disabled and the effort to understand finely stroke 
pathophysiology needs to be sustained.
Ischemic stroke is the result of a permanent or transient occlusion of a major brain artery or one of its 
branches; hence it is a cerebrovascular disease. For decades the main focus of stroke research, and in particular of 
neuroprotection approaches was set on preventing neuronal loss after ischemic injury. More recently, the trend is 
shifting towards viewing neuroprotection from a broader point of view, not focusing only on protecting neurons 
but also addressing the altered physiology of glial cells and of the vascular compartment that can also be involved 
in delayed damage and brain repair mechanisms6–8. The neurovascular unit is an important structural and func-
tional entity, essential for normal brain functioning and homeostasis9. Pathological conditions such as cerebral 
ischemia have a major impact on all elements of the neurovascular unit, namely neurons, astrocytes, juxtavascular 
microglia, endothelial cells and vascular mural cells. While, typically, neurons are damaged or even die, the other 
constituents of the neurovascular unit are also affected and surviving cell populations evolve morphologically and 
functionally to orchestrate a complex chain of events to confine and repair the damage caused by the injury. Here 
we provide a detailed and visual assessment of the changes that affect neurons, glial and endothelial cells over 
time after an ischemic stroke in the mouse brain. We used immunofluorescence analysis to identify the different 
cell types and built maps covering large areas of the mouse brain at different time-points, with striking patterns of 
tissue response to cerebral ischemia. Although earlier studies have investigated some of these tissue changes, we 
provide here a comprehensive and visual global assessment of the interconnected modifications. We then further 
show the evolution of the spatio-temporal changes at higher magnification, focusing on individual cell types. 
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Providing a detailed analysis of the progression of the multicellular response occurring in the neurovascular unit 
after ischemic stroke is an important step towards a better understanding of its spontaneous healing response that 
could pave the way for carefully targeted therapeutic approaches. It could also provide a well-characterised model 
for scientists interested in specific aspects of glial pathophysiology.
Results
Overview of the main cellular types involved in neuroinflammation. An overview of the territorial 
changes in the main components of the neurovascular unit and their interplay is provided on coronal (Fig. 1) 
and sagittal (Fig. 2) sections of brains from mice sacrificed at different time-points after experimental stroke. 
Computerised reconstructions of immunostained sections map the extent of the neuronal damage (loss of MAP-2 
or NeuN signal) and its spatial relation with post-stroke glial (GFAP for astrocytes, Iba1 for microglia, MBP-1 for 
oligodendrocytes) and vascular (CD31 for endothelial cells) reactions.
The mouse striatum is the brain structure most commonly affected by the intraluminal suture MCAO proce-
dure10. Hence, coronal sections showing the striatum were immunostained with markers for the neurovascular 
unit main components at different time-points (Fig. 1). While astrocytes (green sections) slowly become reactive 
and surround the lesion tissue (loss of staining in upper red sections and grey sections), microglia (blue sections) 
show a much faster reaction and populate the area displaying neuronal death and higher vascular reactivity (lower 
purple sections). To note that no evident gross changes are observable in the MBP-1 staining (oligodendrocytes, 
dark-yellow panels) until one week after the MCAO.
To provide an extended point of view of the interplay between the different cell types and the lesion, we per-
formed immunostaining on sagittal cuts of mouse brains (Fig. 2). The first two rows of images show the staining 
of neurons (NeuN, red) and of astrocytes (GFAP, green) and confirm what is shown in the coronal cuts, i.e. that 
the astrocytic reaction evolves at a slowish pace and on the periphery of the lesion, surrounding it. The middle 
two rows show the double staining of neurons (MAP-2, red) and of microglia (Iba1, green). Note how quickly 
highly reactive microglia populate the lesion area, which, although patchy, is evident already at one hour after 
reperfusion and how they show reactivity in areas that do not yet show neuronal loss. The last pair of rows show 
the double staining of neurons (MAP-2, red) and endothelial cells lining the blood vessels (CD31, green). Note 
the higher immunoreactivity of the endothelial cells in the damaged area that increases with time, suggesting a 
neo-vascularization phenomenon, even more prominent at one week (Figs 1, 2).
Figure 1. Coronal overview of the spatio-temporal evolution of the glial and vascular reaction to 30 minutes 
transient middle cerebral artery occlusion with reperfusion. Coronal pseudo-coloured images. Neurons were 
stained with MAP-2 (red) or NeuN (grey), reactive astrocytes were stained with GFAP (green), microglial cells 
were stained with Iba1 (blue), oligodendrocytes were stained with MBP-1 (dark yellow) and endothelial cells 
with CD31 (purple) on coronal sections of mouse brain at the time-points indicated above the images. The 
images shown are representative of at least three animals per time-point.
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Neuronal damage. Neurons are very sensitive to ischemia. The spatio-temporal evolution of neuronal dam-
age after MCAO is illustrated at low (Figs 1, 2) and high (Fig. 3) magnification using MAP-2 or NeuN staining. 
We observe the lesion core, especially using MAP-2 as neuronal marker, as early as one hour after reperfusion 
(Fig. 2), although damage is seen in patches. The lesion is clearly visible and can be already quite extensive by 12 h. 
However, even though MAP-2 signal is lost rather quickly, observing the NeuN staining at early time-points (up 
to 24 h) it is possible to see that the signal from neuronal somata, albeit weaker, is still present (Fig. 3). MAP-2 is a 
cytoskeletal protein strongly expressed in dendrites and less prominent on cell bodies and even though it is likely 
that at early time-points a degree of MAP-2 loss is attributable to the neuronal death, altered MAP-2 levels could 
also be an indicator of dendritic stability. Loss of MAP-2 neurite labelling is demonstrated at higher magnifica-
tion (Fig. 3) at the three hours time-point, which also shows swelling of MAP-2 labelled cell bodies. From 12 h, 
within the lesion area, the few remaining neurites stained with MAP-2 show beading, a typical morphological 
modification of neurites after ischemia11. In parallel, NeuN immunoreactivity, mostly detected in neuronal cell 
bodies, becomes weaker from one hour (Fig. 2). At higher magnification and especially at later time-points (e.g. 
from 24 h) the size of many NeuN labelled nuclei is smaller, which most likely corresponds to pyknosis, reflecting 
apoptotic neuronal death. Overall, Fig. 3 shows that the neuronal markers NeuN and MAP-2 both provide useful 
and distinct information.
Astrocytes. Reactive astrogliosis is a key component of the cellular response to CNS injury12. Astrocytic 
changes following MCAO are illustrated using an antibody against glial acidic fibrillary protein (GFAP), a marker 
of reactive astrocytes (Figs 1, 2, 4). In control brains, there is a strong labelling of fibrous astrocytes in the corpus 
callosum (Fig. 4a “striatum”) and astrocytes in the glia limitans (Fig. 4a “cortex”), together with a weaker label-
ling of some perivascular astrocytes, which cover the circumference of vessels with their endfeet (Fig. 4c). After 
ischemia, hypertrophic reactive astrocytes appear at first (24–48 h) and scar-forming astrocytes later (48 h-one 
week). Although the gradient of astrocytic diversity is not as clear as that observed in trauma-induced injuries13, 
there is topographic diversity of astrocytes with distance from the lesion, as well as locally among neighbouring 
cells. Whereas the hypertrophic reactive astrocytes are seen in the more external part of the peri-lesion area, 
closer to healthy tissue, the scar-forming astrocytes are seen at the boundary of the lesion, with very prominent 
Figure 2. Sagittal overview of the spatio-temporal evolution of the glial and vascular reaction to 30 minutes 
transient middle cerebral artery occlusion with reperfusion. Double immunostaining showing the spatio-
temporal relation of glial (astrocytes, GFAP staining in green; microglia, Iba1 staining in green) and vascular 
endothelial cells (CD31 staining in green) with respect to the lesion (loss of NeuN or MAP-2 staining in red) on 
a sagittal view encompassing a broad array of brain areas. Scale bars: 1 mm. Under each double staining sagittal 
image there is a higher-resolution cropping of the striatal area showing the temporal evolution for astrocytes 
(GFAP, green), microglia (Iba1, green) and endothelial cells (CD31, green). Scale bars: (500 μm).
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Figure 4. Reactive astrocytes. (a) Astrocytes from the ipsilateral striatum (top panels) or cortex (bottom 
panels) of control mice or mice subjected to 30 minutes MCAO were immunostained with GFAP to illustrate 
the evolution of the astrocytic reaction at the time-points indicated above the images. A dashed line indicates 
the boundary of the lesion (L). Scale bar: 100 μm. (b,c) Morphological changes of typical astrocytes found 
within the striatal lesion (b) or in the peri-lesion areas (c) of mice subjected to MCAO are shown using images 
that were thresholded and subsequently binarized. Scale bars: 20 μm. In 48 h (c) and one-week (c) images, 
the two left panels correspond to astrocytes in areas distal from the lesion, whereas the two right panels 
correspond to astrocytes in proximal areas bordering the lesion. (d) Images of the different boundaries between 
astrocytes (GFAP, green) and damaged tissue taken in striatum (left) and cortex (right). The images shown are 
representative of at least three animals per time-point. Scale bar: 50 μm.
Figure 3. Time-course of neuronal loss after MCAO. (a) Neurons were immunostained with NeuN to illustrate 
the evolution of the lesion in the ipsilateral striata of mice subjected to 30 minutes MCAO at the time-points 
indicated above the images. (b) Similarly, neurons were immunostained with a different neuronal marker, 
MAP-2. A dashed line indicates the boundary of the lesion (L). Arrows indicate swollen cell bodies; arrowheads 
indicate neurite beading; hollow arrowheads indicate smaller, condensed nuclei. The images shown are 
representative of at least three animals per time-point. Scale bars: 50 μm.
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GFAP labelling at one week (Figs 1, 4a). In the lesion core area (i.e. the striatum) at three hours, the astrocyte mor-
phology appears mainly normal, whereas it evolves towards cell body swelling, shortening of the processes and 
loss of ramification already from 12 h to one week after injury (Fig. 4a top panels “striatum” and 4b). Conversely, 
in the peri-lesion (Fig. 4a,c), reactive astrocytes do not become prominent until at least 24 h post-ischemia. The 
most striking changes are observed as larger robustness of the main processes, with loss or retraction of the 
very fine processes in the hypertrophic astrocytes (see left panels of the four panels for black-and-white 48 h 
and one-week images, Fig. 4c). In the case of the scar-forming astrocytes bordering the lesion, there is a clear 
directionality to the extension of the thick processes towards the lesion (see right panels of the four panels for 
black-and-white 48 h and one-week images, Fig. 4c) and a high degree of process intertwining, especially one 
week after the injury. Note that there is some variability in the delimitation of the lesion border by astrocytes. In 
some cases, there is a wall-like alignment of GFAP-positive astrocytes defining a sharp border and in other cases; 
the border appears to be less sharp with a more progressive distribution of astrocytes and intertwining of their 
long processes into the lesion (Fig. 4d). Overall, following MCAO there is a large variety of astrocyte morpholo-
gies, as illustrated in Fig. 4b and c, depending on the time-point and distance from the lesion.
Microglia. We labelled microglia using an antibody against Iba1 (ionized calcium-binding adapter mole-
cule 1; Figs 1, 2, 5). Since infiltration of peripheral macrophages into the brain is low for the first few days after 
MCAO14, Iba1-positive cells are likely to be mainly microglia. Iba1 immunoreactivity increases from one hour, 
within the lesion, gradually up to one week, where the intralesional Iba1 labelling is very strong (Figs 1, 2). At 
higher magnification (Fig. 5) one sees at three hours, the long, thin and highly ramified microglial processes 
Figure 5. Microglia. (a) Microglial cells from the ipsilateral striatum (top panels) or cortex (bottom panels) 
of control mice or mice subjected to 30 minutes MCAO were immunostained with GFAP to illustrate the 
evolution of the astrocytic reaction at the time-points indicated above the images. A dashed line indicates the 
boundary of the lesion (L). Scale bars: 50 μm. (b) Morphological changes of typical microglial cells found within 
the striatal lesion (left) or in the peri-lesion areas (right) of mice subjected to MCAO are shown using images 
that were thresholded and subsequently binarized. Scale bar: 20 μm. (c) Single plane images of microglial cells 
stained with Iba1 (red), neurons stained with NeuN (green) and nuclear counterstaining (DAPI, blue) showing 
engulfment of neurons with condensed nuclei (arrowheads) by microglial cells, 48 h after MCAO onset. Scale 
bar: 25 μm. (d) Image of the boundary between the penumbral area and the lesion core, defined by the presence 
or absence of MAP-2 neuronal staining (grey) and delimited by the astrocytic barrier (GFAP staining, green), 
showing the morphological differences of microglial cells (Iba1 staining, red) on either side of the barrier, with 
DAPI as nuclear counterstaining, 48 h after MCAO onset. A dashed line indicates the boundary of the lesion 
(L). The images shown are representative of at least three animals per time-point. Scale bar: 50 μm.
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observed in healthy controls retract. Microglia have been shown to respond to loss of signalling from injured neu-
rons15 and indeed, microglia in the infarct core seem to be initially injured as a result of the ischemia. Processes 
remain retracted at 12 h. At 24 h, microglia become hypertrophic, with enlarged cell bodies, and extend long, wide 
processes while by 48 h, they become more rounded, amoeboid-like, still extending processes that engulf nearby 
structures, especially abundant in the inner boundary of the ischemic lesion. Interestingly, we show phagocytosis 
of NeuN-labelled neurons by activated microglia at 48 h (Fig. 5d). At one week after ischemia, increased numbers 
of Iba1-labelled immune cells populate the lesion core. However, their shape is more elongated than at 48 h and 
remarkably, their distribution respects the architecture of the striatum, as cells seem to clearly avoid the white 
matter bundles that are anatomically characteristic of this brain structure (Fig. 5c). Although the most prominent 
microglial activation occurs within the lesion, there are also changes in Iba1-reactivity and microglial morphol-
ogy in the peri-lesional cortex (Fig. 5a,c). The major changes in microglial morphology in the peri-lesion seem 
to happen at 48 h post-injury, although at one-week after ischemia; strong activation in penumbra is still evident. 
Two days after reperfusion, in the boundary zone between the ischemic lesion core and the penumbral area pop-
ulated by abundant GFAP positive cells, (Fig. 5d) amoeboid cells in the ischemic core can be distinguished from 
highly ramified microglia on the other side of the astrocytic barrier. Engulfment of stressed but viable neurons 
(which may expose phosphor-serine) in the ischemic penumbra of experimental stroke lesions amplifies overall 
tissue damage and worsens behavioural outcomes16,17. Hence, the astrocytic scar, acting as a barrier to the pen-
etration of reactive microglia or even inflammatory cells infiltrated from the periphery, would be a protective 
entity.
Proinflammatory and repair-promoting cytokines. We looked at the expression of the proinflamma-
tory cytokine IL-1β (Fig. 6) and the repair-promoting cytokine TGFβ1 (Fig. 7). IL-1β is detected in the striatum 
of control mice. After MCAO, there are two waves of IL-1β expression, a large widespread diffuse increase at three 
hours and a more focalized one in what looks like localized accumulation of the cytokine at one week (Fig. 6a, 
Fig. 8a). Double-labelling experiments show coexpression of IL-1β with both GFAP (Fig. 6b) and Iba1 (Fig. 6c). 
The cytokine is detected in GFAP-positive cells in healthy controls and shows a gradual increase after ischemia, 
with a punctate labelling pattern in the cell body and along astrocytic main processes (as seen in single-plane 
confocal images, Fig. 6b). Note that the images of GFAP positive cells in the higher magnification panels from 
24 h onwards are in the peri-lesion and not all cells are positive for IL-1β. On the other hand, microglial cells do 
not appear to substantially express IL-1β until 24–48 h after MCAO (Fig. 6c). Especially one week after ischemia, 
we observe different degrees of IL-1β expression in Iba1-positive cells present in the lesion core.
The repair-promoting cytokine TGFβ1 is weakly expressed in the striatum in control conditions (Fig. 7). After 
MCAO, similarly to IL-1β, its expression increases in two waves, slightly at three hours and more pronouncedly 
at 48 hours-one week (Figs 7a, 8b). Double-labelling experiments show that TGFβ1 colocalises with both GFAP 
(Fig. 7b) and Iba1 (Fig. 7c) indicating that both activated astrocytes and microglia express TGFβ1. To note that 
the images of GFAP-positive cells in the higher magnification panels from 24 h onwards are from the peri-lesion. 
Interestingly, the expression of TGFβ1 in astrocytes seems stronger at 48 h than one week after ischemia and at the 
latter time-point; there is abundant TGFβ1 labelling beyond astrocytic and microglial signals. Information on the 
circulating levels of these two cytokines in the MCAO stroke model can be found elsewhere18,19.
Oligodendrocytes. We labelled oligodendrocytes using an antibody against MBP-1 (myelin basic protein 1). 
At low magnification (Fig. 1) no striking changes were observed. Changes not evident at low magnification are 
detectable at higher magnification and mostly seen as a destructuring of the cellular network, first in the lesion 
area (3 to 24 h) followed by cell loss at later time-points (Fig. 9). At one week, double labelling with NeuN shows 
reduced MBP-1 immunoreactivity in the peri-lesional cortex and loss of labelling in both processes and cell bod-
ies in the lesion core (striatum).
Blood vessels. Blood vessels and vascular mural cells were labelled using antibodies against the mainly 
endothelial protein, CD31 and a pericyte marker, PDGFR-β1. As shown in Figs 1 and 2, there is a strong increase 
over time of CD31 labelling within the striatal lesion. At higher magnification (Fig. 10a), the same enhancement 
of CD31 labelling is observed, starting at three hours and becoming very strong at 48 h and one week. The peri-
cyte labelling starts to be quite evident from 12 h and becomes very strong at one week. Interestingly, on double 
labelling (Fig. 10b), we see that PDGFR-β1-positive cells display a typically ‘bump-on-a-log’ labelling at 24 h 
(arrows). However, it seems that they completely cover and constrict the capillaries by one week (arrowheads), 
hinting at an active role in blood-flow restriction at this time-point. In fact, whereas the volume occupied by 
CD31-positive cells in the lesion increases by almost two-fold at 48 h to decrease to control levels by one week, the 
volume of PDGFR-β1-positive cells increases several fold at one week (Fig. 10c).
Discussion
Here we provide a comprehensive and visual mapping of the evolution of the multicellular response to stroke in 
one of the most widely used mouse models of transient cerebral ischemia. The use of large extension maps allows 
a better illustration and localization of the territorial boundaries of the bulk post-stroke changes as done classi-
cally for lesion extension evaluation. Additionally, the approach of first looking at the ‘big picture’ followed by 
higher-magnification images to get a closer look at the cellular and molecular events occurring in specific areas 
of interest gives us a wider perspective of where things happen, an important issue often neglected in a largely 
inhomogeneous organ like the brain.
Using this strategy we visually illustrate the spatio-temporal evolution of events that fall into each one of the 
three overlapping but distinct phases of the multicellular response to acute focal CNS damage (such as the one 
modelled by MCAO) described by Burda and Sofroniew20. These are (1) cell death and inflammation, (2) cell 
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proliferation for tissue replacement, and (3) tissue remodelling. During the initial phase of cell death and inflam-
mation, corresponding to our 1–12 h time-points, we observe suffering/loss of neurons, astrocytes and even 
microglia in the lesion core area (Figs 1–4). These events are temporally correlated with an overall increase of 
the proinflammatory cytokine IL-1β (Fig. 6, first wave of increase at three hours). The 24–48 h time-points corre-
spond to cell proliferation and tissue replacement phase. At these time-points we observe increased numbers of 
GFAP-positive cells in the peri-lesion area (Fig. 4) and an increase in vascular reactivity within the striatal lesion 
core that goes together with a notable presence of peri-vascular PDGFRβ-1-positive cells (Fig. 9), suggestive of 
neo-vascular remodelling. In addition, the activity of phagocytic microglia clearing debris associated with neu-
ronal death (Fig. 5) and the strong signal for TGFβ1 in astrocytes, microglia and other cells in the lesion (Fig. 7) 
favour the idea of tissue modification-replacement. Finally, in the third phase of tissue-remodelling (48h-one 
week), there is massive presence of PDGFRβ-1-positive cells, not only covering the vessels but also in the paren-
chyma of the lesion, indicative of stromal cells, hence of a fibrotic scar. Also the establishment of a clear astrocytic 
scar delimiting the vast invasion of inflammatory cells into the neighbouring healthy tissue, concomitant with a 
Figure 6. Temporal evolution of the proinflammatory marker Interleukin-1β (IL-1β) after 30 minutes MCAO. 
(a) Low magnification images from ipsilateral to lesion striatal tissue sections taken at different time-points 
after ischemia and immunostained for IL-1β (red). A dashed line indicates the boundary of the lesion (L). Scale 
bar: 50 μm. Sections were counterstained for reactive astrocytes ((b), GFAP staining in green) or microglia 
((c), Iba1 staining in green) and shown at higher magnification. Arrows (astrocytes) or arrohweads (microglia) 
point towards cells that express IL-1β. DAPI (blue) was used as a nuclear counterstaining. The images shown are 
representative of at least three animals per time-point. Scale bars: 20 μm.
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large expression of TGFβ1 and IL-1β in the tissue devoid of neurons. Both the damaged and remaining healthy 
tissue will progress into this third phase, but the main aim of our time-course was to describe the early days after 
infarction.
Traditional preclinical stroke research has aimed therapy design at preventing neuronal death, immediate or 
delayed. However, besides the immediate neuronal damage caused by the harsh environmental conditions due 
to ischemia, a considerable amount of the post-stroke damage to CNS tissue is via secondary injury, through 
microglial activation, capillary pericyte constriction and numerous other mechanisms. Interestingly, this early 
potentially deleterious response to acute injury is also the trigger for the reparative events that follow. It is of note 
that therapeutic interventions targeting post-ischemic inflammation should be mindful of temporal consider-
ations, minimizing the destructive potential of inflammation in the acute phase while enhancing its beneficial 
contributions to tissue repair in the late stages of cerebral ischemia8. Indeed, learning how, when and where these 
protective mechanisms are triggered and implemented may be of great help in the quest to treat stroke. Recently, 
therapies targeted to non-neuronal cell populations have aimed to abrogate indirect neuronal degeneration, as 
Figure 7. Temporal evolution of the tissue-repair cytokine Transforming Growth Factor β1 (TGFβ1) after 
30 minutes MCAO. (a) Low magnification images from ipsilateral to lesion striatal tissue sections taken at 
different time-points after ischemia and immunostained for TGFβ1 (red). A dashed line indicates the lesion 
boundary (L). Scale bar: 50 μm. Sections were counterstained for reactive astrocytes ((b), GFAP staining 
in green) or microglia ((c), Iba1 staining in green) and shown at higher magnification. Arrows (astrocytes) 
or arrohweads (microglia) point towards cells that express TGFβ1. DAPI (blue) was used as a nuclear 
counterstaining. The images shown are representative of at least three animals per time-point. Scale bars: 20 μm.
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Figure 8. Semi-quantitative evaluation of IL-1β and TGFβ1. Temporal evolution of tissue IL-1β (a) and TGFβ1 
(b) levels, normalized to controls. The graphs show the mean and standard deviation of images collected on 
samples from two (IL-1β) or three (TGFβ1) different sets of experiments. **p < 0.01; ***p < 0.001, one-way 
ANOVA with Tukey post-hoc test.
Figure 9. Oligodendrocytes. (a) Oligodendrocytes from the ipsilateral striatum of control mice or mice 
subjected to 30 minutes MCAO were immunostained for Myelin Basic Protein 1 (MBP-1) to illustrate the 
damage caused to oligodendrocytes at the time-points indicated above the images. Images were taken in the 
lesion area. Scale bar: 50 μm. (b) Higher magnification, single plane images comparing healthy (left panels) 
and one-week after stroke (right panels) tissue from striatum or cortex stained for MBP-1 (green) and NeuN 
(neurons, red) with blue DAPI counterstaining. The images shown are representative of at least two animals per 
time-point. Scale bar: 20 μm.
www.nature.com/scientificreports/
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well as to enhance endogenous repair mechanisms21. Interestingly, the most successful trial for endovascular 
stroke therapy to date4 was based on choosing patients that had salvageable penumbral tissue, tissue that is clearly 
affected by the neuroinflammation and repair processes we are imaging at low scale. Furthermore, it has been 
recently shown that some benefits of reperfusion by endovascular clot removal may go beyond the rescue of neu-
rons by enhancing the brain’s repair mechanisms22.
Neuroprotection strategies targeting the functional integrity of astrocytes, for example, may constitute a supe-
rior strategy for future neuroprotective therapies. It has been proposed that the astrocyte-scar border serves as a 
protective barrier that restricts the migration of inflammatory cells from the injured lesion core into surrounding 
viable neural tissue13,23. These functional astrocytic barriers sharply demarcate tissue compartments in which 
robust inflammatory responses essential for clearing debris can develop13 and set a permissive environment for 
the creation of a dense fibrotic scar made by stromal cells24, while preserving immediately adjacent viable and 
functional neural tissue. This compartmentalization can be observed after experimental stroke as illustrated by 
Figure 10. Time-course of the vascular remodelling and stromal reaction after MCAO. (a) Endothelial cells 
(CD31 staining, green) and pericytes and stromal cells (PDGFRβ-1, red) from within the ipsilateral striatum 
of control mice or mice subjected to 30 minutes MCAO were immunostained to illustrate the evolution of the 
changes in the vascular system in the lesion as well as the stromal cell reaction at the time-points indicated 
above the images. Scale bar: 50 μm. (b) Higher magnification images taken at selected time-points and 
immunostained for CD31 (green) and PDGFRβ-1 (red). DAPI (blue) was used as nuclear counterstaining. 
Arrows indicate pericytes; arrowheads indicate constriction. Scale bar: 25 μm. (c) Quantification of the volume 
of CD31-positive cells (left), PDGFRβ-1-positive cells (middle) and the PDGFRβ-1/CD31 volume ratio (right). 
To avoid interference of the background noise, only images of PDGFRβ-1 from 24 h onwards were considered. 
The graphs show the mean and standard deviation of images collected on samples from three different sets of 
experiments. ***p < 0.001; ****p < 0.0001, one-way ANOVA with Tukey post-hoc test. The images shown are 
representative of at least three animals per time-point. Although the volume of CD31-labelled cells has returned 
to volumes observed in control mice one week after MCAO, the CD31-labelling intensity remains stronger.
www.nature.com/scientificreports/
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the differences in microglial morphology on either side of the astrocytic barrier in Fig. 5d, with the amoeboid-like 
cells being those that phagocyte condensed neuronal nuclei confined within the lesion (Fig. 5c,d), and impor-
tantly it can also be observed after stroke in humans25. In cerebral ischemia, mutant mice lacking an efficient 
astroglial scar in the case of a vimentin and GFAP double knockout26 or in the absence of Caveolin-127 develop 
larger lesions and impaired neurological outcome. The astroglial scar not only keeps phagocytic reactive micro-
glia at bay, but also neatly delimitates the fibrotic scar as cellular and molecular constituents of the fibrotic scar 
induce the repulsion and polarization of astrocytes6. Furthermore, both scars seem to act in a cooperative way, 
as it has been suggested that efficient fibrotic formation within areas of infarct may promote peri-infarct astro-
gliosis28. A better understanding of the multicellular and molecular interactions that determine the location of 
astrocyte scar borders around areas of compromised tissue may lead to novel therapeutic strategies for reducing 
lesion size. These events occur over a time frame of days after the insult, offering a favorable therapeutic window 
during which intervention is a realistic possibility.
Another interesting feature of the brain recovering from stroke that could be considered as a target for therapy 
is the complex pattern of vascular remodeling. Angiogenesis is promoted by hypoxia29 and it has been detected 
in rodent models of cerebral ischemia30. We show a striking change in vascular labelling with enhanced immu-
noreactivity for the endothelial marker CD31 within the striatal ischemic lesion (Figs 1,2). With a slight delay we 
observe the increased expression of the pericyte and stromal cell marker PDGFR-β1 and an apparent widening 
of the vessels at 24–48 h post-injury (Fig. 9). As metabolic and clearance needs of the brain tissue might drive 
the delivery of blood flow31, this widening could be related to a potential need of cerebral blood flow increase in 
order to clear the brain of potentially toxic by-products of brain activity, as well as for brain thermoregulation. 
Contrarily, at one week our images show constriction of capillaries by PDGFR-β1 positive cells, suggesting a role 
in cerebral blood flow control. Also, pericytes are necessary for endothelial cells in the blood-brain barrier to 
repress endothelial transcytosis32. Further experiments are required to correlate our observations with blood-flow 
regulation and blood-brain barrier function.
A typical way of evaluating the efficacy of a treatment in preclinical stroke research has been to assess the 
reduction of neuronal death extension after the intervention as a primary outcome measure. However, it is 
becoming evident that the functional outcome is not always necessarily correlated with the overall extension of 
the lesion core33. It is beyond the scope of this work to relate a particular astrocyte, microglial or vascular mor-
phology or distribution to a better functional outcome. However, it will be interesting to measure the effects of a 
therapeutic intervention both in terms of lesion size and the associated multicellular response that accompanies 
the different recovery phases post-stroke. Similarly, it would be interesting to correlate the distribution of the 
astrocytic scar and the microglial response with the behavioural outcome of mice after stroke following thera-
peutic interventions and to find what kind of intervention might promote better establishment of an astrocytic 
isolating-scar without further compromising the viability of the tissue. One potential approach to find new ther-
apies could be to take into account the beneficial aspects of the repair processes that happen naturally after the 
damage and potentially enhance them for a better or faster functional recovery, thus lowering the disability index 
associated with stroke.
Materials and Methods
Animal Model. All experiments were performed in accordance with Swiss Laws for the protection of ani-
mals and were approved by the Vaud Cantonal Veterinary Office. Male C57BL/6J mice (37 animals, body weight 
19–25 g, aged 4–8 weeks; Charles River, France) had free access to food and water and were maintained on a 
12 h light-dark cycle in a temperature- and humidity-controlled animal facility. Surgeries were performed under 
isoflurane anesthesia (1.5–2% in 70% N2O/30% O2) using a facemask. Mice were administered buprenorphine 
(0.025 mg/kg, subcutaneous injection) at the beginning of the surgery for post-surgery analgesia. Rectal temper-
ature was monitored throughout surgery and maintained at 37.0 ± 0.5 °C using a heating pad (FHC Inc., USA). 
A flexible probe was fixed on the skull at 1 mm posterior and 6 mm lateral from bregma to measure and record 
throughout the surgery regional cerebral blood flow (rCBF) by laser-Doppler flowmetry (Perimed AB, Sweden). 
Transient focal cerebral ischemia was induced by introducing through the left common carotid artery into the 
internal left carotid artery a silicon-coated nylon suture (Doccol Corp, USA) to occlude the left middle cere-
bral artery (MCA) for 30 minutes, after which the occluding filament was withdrawn to allow reperfusion, as 
described previously34,35. Surgery was considered successful if rCBF was <20% of baseline during the 30 minutes 
occlusion and >50% of baseline after reperfusion. After the surgery mice were housed in an incubator at 28° C 
until sacrifice or overnight.
At indicated time-points after ischemia-reperfusion, three (3 h, 12 h) to six (control, 24 h, 48 h, 1 week) mice 
per time-point for the coronal sections and one mouse per time-point for the sagittal sections were sacrificed by 
intraperitoneal injection of 150 mg/kg sodium pentobarbital and intracardially perfused with 4% paraformalde-
hyde in phosphate buffer at pH 7.4.
Immunostaining. For immunofluorescence labelling, 40 μm free-floating cryostat sections (25 μm sections 
for the sagittal cuts) were pre-incubated in 10% horse serum and 0.3% Triton X-100-PBS-1% BSA and then 
incubated over two days at 4 °C with primary antibodies in 2% horse serum and 0.3% Triton X-100-PBS-1% BSA 
(0.1% Triton X-100 and overnight incubation for the 25 μm sections), washed in PBS, and incubated in Alexa 
Fluor-coupled secondary antibodies (ThermoFisher-Molecular Probes) and DAPI for nuclear counterstaining 
one hour at room temperature, rinsed in PBS and mounted in FluorSave™ (Calbiochem, #345-789-20). The 
antibodies used were as follows: anti-Microtubule Associated protein 2 (MAP-2) mouse monoclonal (Millipore 
#MAB3418, 1:400), anti-Neuronal Nuclear antigen (NeuN) mouse monoclonal (Millipore #MAB377, 1:400), 
anti-Glial Fibrillary Acidic protein (GFAP) mouse monoclonal (Millipore #MAB3402, 1:2000), anti-GFAP rabbit 
polyclonal (Millipore #AB5804, 1:2000), anti-Ionized calcium Binding Adaptor molecule 1 (Iba1) goat polyclonal 
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(Abcam #ab5076, 1:400), anti-Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1, also known as CD31) 
rat monoclonal (BD Pharmingen #550274, 1:100), anti-Myelin Basic Protein 1 (MBP-1) rat monoclonal anti-
body (Millipore #MAB386, 1:600), anti-IL-1β antibody (Santa Cruz Biotechnology #sc-7884, 1:100), anti-TGFβ1 
mouse monoclonal antibody (R&D Systems #MAB240, 1:200) and anti-platelet-derived growth factor receptor 
β-1 (PDGFRβ-1) rabbit polyclonal antibody (Santa Cruz Biotechnology #sc-432, 1:200).
Image acquisition and processing. Images of coronal cuts were taken at 5x magnification with an 
Axioplan2 microscope (Carl Zeiss, Germany) and manually stitched using ImageJ stitching plugin36. Images of 
sagittal cuts were taken at 10x magnification and stitched with a Zeiss Z1 slide scanner (Carl Zeiss, Germany). 
Confocal laser microscopy was performed with a TCS SP5 RS – DM6000 confocal scanning microscope (Leica, 
Germany) at 20x (HC PL Fluotar, NA 0.5, air), 40x (HCX PL APO, NA 1.25, oil) or 63x (HCX APO, NA 1.40, oil) 
magnification. Unless otherwise stated, representative confocal images are displayed as maximal z-projections. 
For double or triple labelling, immunofluorescence signals were sequentially acquired in the same section. For 
the semi-quantitative evaluation of tissue cytokine levels, the raw integrated density of maximal z-projections of 
images taken at 63x in three random areas of the lesion of two (IL-1β) or three (TGFβ1) mice per time-point was 
measured and normalized against control samples. For the evaluation of the volumes of CD31- and PDGFRβ-
1-positive cells, 63x z-stacks (11–14 images, z = 1.5 μm) of at least three random areas of the lesion of three mice 
per time-point were smoothed (3D Gaussian filter) and processed with the 3D object counter plugin from ImageJ. 
The results are expressed as a percentage of the total volume of the z-stack.
Images were processed and quantified with Fiji/ImageJ software (NIH, USA) and Adobe Photoshop CS5 
(Adobe, USA).
Statistical analysis. Comparisons between variables were analyzed by one-way ANOVA followed by Tukey’s 
post-hoc test. All statistical tests were carried on GraphPad Prism 6.0 (GraphPad Software, USA). Significance was 
considered at p < 0.05.
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